Cargando…

Novel covalent and non-covalent complex-based pharmacophore models of SARS-CoV-2 main protease (M(pro)) elucidated by microsecond MD simulations

As the world enters its second year of the pandemic caused by SARS-CoV-2, intense efforts have been directed to develop an effective diagnosis, prevention, and treatment strategies. One promising drug target to design COVID-19 treatments is the SARS-CoV-2 M(pro). To date, a comparative understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayek-Orduz, Yasser, Vásquez, Andrés Felipe, Villegas-Torres, María Francisca, Caicedo, Paola A., Achenie, Luke E. K., González Barrios, Andrés Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386674/ https://www.ncbi.nlm.nih.gov/pubmed/35982147 http://dx.doi.org/10.1038/s41598-022-17204-0

Ejemplares similares

In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking
por: Vázquez-Mendoza, Luis Heriberto, et al.
Publicado: (2022)

Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
por: Nemukhin, A. V., et al.
Publicado: (2022)

Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation
por: Alamri, Mubarak A., et al.
Publicado: (2021)

Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide
por: Yamane, Daiki, et al.
Publicado: (2022)

Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
por: Kneller, Daniel W., et al.
Publicado: (2022)

Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease
por: Yang, Kai S., et al.
Publicado: (2022)

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
por: Kim, Hoshin, et al.
Publicado: (2022)

Alkyne as a Latent Warhead to Covalently Target SARS-CoV-2 Main Protease
por: Ngo, Chau, et al.
Publicado: (2023)

Boroleucine‐Derived Covalent Inhibitors of the ZIKV Protease
por: Braun, Niklas J., et al.
Publicado: (2022)

Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro
por: Kato, Yoji, et al.
Publicado: (2021)

Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease
por: Lipiński, Piotr F.J., et al.
Publicado: (2021)

Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors
por: Kovalevsky, Andrey, et al.
Publicado: (2023)

Elucidation of Antimicrobial Activity of Non-Covalently Dispersed Carbon Nanotubes
por: Saleemi, Mansab Ali, et al.
Publicado: (2020)

Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease
por: Delre, Pietro, et al.
Publicado: (2020)

Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease
por: Selvaraj, Chandrabose, et al.
Publicado: (2021)

Covalent bonds in positron dihalides
por: Moncada, Félix, et al.
Publicado: (2019)

Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
por: Lockbaum, Gordon J., et al.
Publicado: (2021)

Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease
por: Macchiagodena, Marina, et al.
Publicado: (2022)

Identification of and Mechanistic Insights into SARS-CoV-2 Main Protease Non-Covalent Inhibitors: An In-Silico Study
por: Shen, Jian-Xin, et al.
Publicado: (2023)

An integrated metabolomic and proteomic approach for the identification of covalent inhibitors of the main protease (M(pro)) of SARS-COV-2 from crude natural extracts
por: Baron, Giovanna, et al.
Publicado: (2023)

Identification of covalent active site inhibitors of dengue virus protease
por: Koh-Stenta, Xiaoying, et al.
Publicado: (2015)

High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors
por: Sepehri, Bakhtyar, et al.
Publicado: (2021)

Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection
por: Ge, Rui, et al.
Publicado: (2022)

Covalent adduction of serotonin-derived quinones to the SARS-CoV-2 main protease expressed in a cultured cell
por: Kato, Yoji, et al.
Publicado: (2023)

Chitosan Functionalization: Covalent and Non-Covalent Interactions and Their Characterization
por: Nicolle, Laura, et al.
Publicado: (2021)

Covalent and Non-covalent Functionalized Nanomaterials for Environmental Restoration
por: Zhang, Shizhong, et al.
Publicado: (2022)

Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CL(pro)) Non-Covalent Small-Molecule Inhibitors
por: Jukič, Marko, et al.
Publicado: (2020)

Structural elucidation of recombinant Trichomonas vaginalis 20S proteasome bound to covalent inhibitors
por: Silhan, Jan, et al.
Publicado: (2023)

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
por: Brewitz, Lennart, et al.
Publicado: (2023)

DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors
por: Jimmidi, Ravikumar, et al.
Publicado: (2023)

Synthesis of the Novel Covalent Cysteine Proteases Inhibitor with Iodoacetic Functional Group
por: Hartman, Kinga, et al.
Publicado: (2020)

Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition
por: Liang, Julia, et al.
Publicado: (2022)

Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors
por: Zain, Rula, et al.
Publicado: (2021)

Covalent and non-covalent chemistry of 2D black phosphorus
por: Mitrović, Aleksandra, et al.
Publicado: (2021)

Correction to: Covalent and Non-covalent Functionalized Nanomaterials for Environmental Restoration
por: Zhang, Shizhong, et al.
Publicado: (2022)

Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARγ ligands
por: Bae, Hwan, et al.
Publicado: (2016)

Elucidating the Aromatic Properties of Covalent Organic Frameworks Surface for Enhanced Polar Solvent Adsorption
por: Borzehandani, Mostafa Yousefzadeh, et al.
Publicado: (2021)

Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage
por: Shi, Tzu-Hau, et al.
Publicado: (2020)

CovalentDock Cloud: a web server for automated covalent docking
por: Ouyang, Xuchang, et al.
Publicado: (2013)

Constructing covalent organic frameworks in water via dynamic covalent bonding
por: Thote, Jayshri, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m1rrfk94devdvuenmt34g5hsj7